delphinidin has been researched along with Orbital Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Cadmus, SD; Thelin, LL; Vrcek, I | 1 |
Beyer-Machule, CK; Hintschich, CR; Stefani, FH | 1 |
Geiger, K; Witschel, H | 1 |
Büttner, C; Geiger, K; Witschel, H | 1 |
Braunstein, S; Cartsburg, O; Jungblut, D; Sundmacher, R | 1 |
5 other study(ies) available for delphinidin and Orbital Diseases
Article | Year |
---|---|
Orbital granuloma formation following autoinjection of paraffin oil: management considerations.
Topics: Granuloma; Humans; Oils; Orbital Diseases; Paraffin | 2020 |
Paraffinoma of the periorbit--a challenge for the oculoplastic surgeon.
Topics: Adult; Female; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Ointments; Orbital Diseases; Paraffin; Paranasal Sinus Diseases; Surgery, Plastic | 1995 |
Paraffin induced sclerosing lipogranuloma of eyelids and anterior orbit following endonasal sinus surgery.
Topics: Adult; Eyelid Diseases; Female; Granuloma; Humans; Male; Middle Aged; Orbital Diseases; Paraffin; Paranasal Sinuses; Postoperative Complications; Retrospective Studies; Sclerosis | 1994 |
[Chronic lipogranuloma (paraffin granuloma) of the eyelids and orbits after endonasal paranasal sinus operation].
Topics: Adult; Endoscopy; Ethmoid Sinusitis; Eyelid Diseases; Eyelids; Female; Follow-Up Studies; Granuloma; Humans; Male; Maxillary Sinusitis; Middle Aged; Orbit; Orbital Diseases; Paraffin; Postoperative Complications; Reoperation | 1993 |
[Long-term results after therapy of paraffin induced sclerosing lipogranuloma of the eyelids and the anterior orbit in three patients].
Topics: Adult; Contraindications; Eyelid Diseases; Female; Granuloma, Foreign-Body; Humans; Male; Middle Aged; Ophthalmologic Surgical Procedures; Orbital Diseases; Otorhinolaryngologic Surgical Procedures; Paraffin; Sclerosing Solutions; Secondary Prevention; Treatment Outcome | 2001 |